O
Optina Diagnostics
Biotech & Life Sciences · Montreal, Canada · Founded 2011
Technology for the early detection of disease through the eye MoreLess
Optina Diagnostics is pioneering the development of a groundbreaking tool designed to identify beta amyloid AB plaques, which are crucial biomarkers for Alzheimer's disease. The company operates in the healthcare diagnostics market, focusing on early detection of neurodegenerative diseases through non-invasive eye scans. Optina Diagnostics primarily serves healthcare providers, research institutions, and clinical study organizations. The business model revolves around selling and licensing its diagnostic technology to these clients, generating revenue through product sales, service agreements, and collaborative research projects. By leveraging advanced imaging techniques and artificial intelligence, Optina Diagnostics aims to revolutionize the early diagnosis of Alzheimer's, potentially altering the course of treatment and management for millions of patients worldwide. The company is also actively involved in community patient access programs to broaden the reach of its diagnostic solutions.
Keywords: Alzheimer's, beta amyloid, eye scan, diagnostics, healthcare, neurodegenerative, imaging, artificial intelligence, early detection, biomarkers.
Company overview
Optina Diagnostics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2011
- Headquarters
- Montreal, Canada
- Employees
- 23
- Open positions
- None listed
- Dealroom signal
- 29.6
Valuation & funding
Optina Diagnostics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jan 2022 | $2.1M | $124M | Desjardins Capital · DigitalDx Ventures · Boehringer Ingelheim Venture Fund · Zoic Capital | ↗ |
| SERIES A✓Equity / VC | Oct 2021 | $25M | $99M | Boehringer Ingelheim Venture Fund · Desjardins Capital · DigitalDx Ventures · Advisors.Fund | ↗ |
| SEED✓Equity / VC | Jun 2019 | — | — | Innovacorp · Anges Quebec · MEDTEQ+ · Real Ventures | — |
| SEED✓Equity / VC | Oct 2018 | $3.1M | $12M | Zoic Capital · Pallasite Ventures · Desjardins Capital · Advisors.Fund | — |
| GRANTOther financing | Oct 2017 | $0 | — | Undisclosed | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 23 |
| 2025 | 25 |
| 2024 | 33 |
| 2023 | 41 |
| 2022 | 40 |
| 2021 | 26 |
Growth signals
Optina Diagnostics website traffic
Latest recorded traffic for Optina Diagnostics is 1.3K monthly website visits, up 381.5% over the last three months. Optina Diagnostics's team declined 8% over the past year.
Comparisons
Optina Diagnostics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Optina Diagnostics's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Optina Diagnostics has talent and traffic
team presence
In the news
Latest news about Optina Diagnostics
Recent press, funding announcements, and product moves mentioning Optina Diagnostics — open to read from the original sources.
Market sentiment
What the market is saying about Optina Diagnostics
An AI-synthesized read of the highest-engagement posts about Optina Diagnostics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Optina Diagnostics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.